|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 374-380, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
SV Lichtenstein, JG Abel and AS Slutsky
Hypothermia is believed to be the most important aspect of successful
myocardial protection with retrograde coronary sinus cardioplegia. Because
nutritive capillary flow to the right ventricle and septum is thought to be
diminished with retrograde perfusion, these areas of the myocardium are
considered at higher risk for intraoperative deterioration without the
added protection of hypothermia. Recently we introduced warm aerobic arrest
as an alternative to conventional methods of myocardial protection. We
present our clinical results in 37 patients with mitral valve disease (+/-
aortic valve, aortic root, or coronary artery disease) who underwent
various cardiac procedures for which warm blood cardioplegic solution was
delivered continuously via the coronary sinus after antegrade arrest.
Thirty-five of the patients were in New York Heart Association class III or
IV, and 19 patients had grade 3 or grade 4 left ventricular function.
Sixteen patients had pulmonary hypertension, three with suprasystemic
pressures, and marked right ventricular hypertrophy. Two patients had
associated left ventricular hypertrophy. Nearly all patients returned to
normal sinus rhythm shortly after removal of the aortic crossclamp, and
they were easily discontinued from cardiopulmonary bypass even with
crossclamp times of 3 hours. The 30-day hospital mortality rate was 2.7%.
The perioperative myocardial infarction rate was 5.4%, and the prevalence
of low-output syndrome was 10.8%. The results suggest that retrograde
coronary sinus perfusion of blood cardioplegic solution at 37 degrees C is
an effective method of myocardial protection even in patients with
pulmonary hypertension at high risk for right ventricular failure. Its
efficacy in this circumstance does not reside in its ability to deliver
hypothermia.
ARTICLES
Warm retrograde cardioplegia. Protection of the right ventricle in mitral valve operations
Department of Surgery, St. Michael's Hospital, University of Toronto, Ontario, Canada.
This article has been cited by other articles:
![]() |
F. Dagenais, L. C. Pelletier, and M. Carrier Antegrade/retrograde cardioplegia for valve replacement: a prospective study Ann. Thorac. Surg., November 1, 1999; 68(5): 1681 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ardehali, H. Laks, D. C. Drinkwater Jr, R. N. Gates, and E. Kaczer Ventricular Effluent of Retrograde Cardioplegia in Human Hearts Has Traversed Capillary Beds Ann. Thorac. Surg., July 1, 1995; 60(1): 78 - 82. [Abstract] [Full Text] |
||||
![]() |
T. Asai, E. A. Grossi, M. LeBoutillier III, M. A. Parish, F. G. Baumann, F. C. Spencer, S. B. Colvin, and A. C. Galloway Resuscitative retrograde blood cardioplegiaAre amino acids or continuous warm techniques necessary? J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 242 - 248. [Abstract] [Full Text] |
||||
![]() |
P. Menasche, S. Haydar, J. Peynet, C. D. Buit, R. Merval, G. Bloch, A. Piwnica, and A. Tedgui A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 293 - 299. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |